Tag: aseptic processing

Periodic Review of CCS: Triggers, Scope and Outputs | Pharma GMP Guide Conducting a Periodic Review of Contamination Control Strategy (CCS): Step-by-Step Guide for Aseptic Manufacturing Ensuring the robustness and compliance of contamination control strategies (CCS) within aseptic manufacturing environments is critical for sterility assurance and patient safety. Regulatory authorities in the US, UK, and…

Read More “Periodic Review of CCS: Triggers, Scope and Outputs” »

How Annex 1 Has Changed the Role of Microbiology in GMP Sites How Annex 1 Has Changed the Role of Microbiology in GMP Sites: A Step-by-Step Guide For pharmaceutical manufacturing sites engaged in aseptic manufacturing, understanding and complying with Annex 1 of the EU GMP guidelines has become paramount. The recent revision of Annex 1…

Read More “How Annex 1 Has Changed the Role of Microbiology in GMP Sites” »

Aligning Contamination Control Strategy With Corporate Sterility Assurance Policies Step-by-Step Guide to Aligning Contamination Control Strategy With Corporate Sterility Assurance Policies The pharmaceutical industry’s sterile manufacturing sectors face increasingly stringent requirements to ensure product sterility and patient safety. A robust contamination control strategy (CCS) aligned with corporate sterility assurance policies is critical for compliance with…

Read More “Aligning Contamination Control Strategy With Corporate Sterility Assurance Policies” »

Lessons From Major Contamination Events in Sterile Manufacturing Critical Lessons From Contamination Events in Aseptic Manufacturing and Annex 1 Compliance Ensuring sterility assurance during aseptic manufacturing remains a primary focus for pharmaceutical manufacturers globally. Over the past decades, multiple major contamination events have exposed vulnerabilities in contamination control systems, especially within Grade A and B…

Read More “Lessons From Major Contamination Events in Sterile Manufacturing” »

Blueprint for an Inspection-Ready Annex 1 Contamination Control Strategy Step-by-Step Guide to Designing an Inspection-Ready Annex 1 Contamination Control Strategy for Aseptic Manufacturing The revision and implementation of Annex 1 (EU GMP Volume 4, Chapter 1) have heightened expectations regarding contamination control strategies (CCS) in sterile pharmaceutical manufacturing. Pharmaceutical professionals across the US, UK, and…

Read More “Blueprint for an Inspection-Ready Annex 1 Contamination Control Strategy” »

Contamination Control in Single-Use Bioreactor and Manifold Set-Ups Comprehensive Step-by-Step Guide to Contamination Control in Single-Use Bioreactor and Manifold Set-Ups Single-use bioreactors (SUBs) and manifold assemblies have revolutionized aseptic manufacturing by reducing cleaning demands and improving operational flexibility. However, their complex nature also necessitates stringent contamination control strategies to meet regulatory expectations and ensure sterility…

Read More “Contamination Control in Single-Use Bioreactor and Manifold Set-Ups” »

Managing Consumables (Wipes, Mops, Garments) in CCS and EM Programs Comprehensive Guide: Managing Consumables in Contamination Control and Environmental Monitoring Programs In sterile pharmaceutical manufacturing environments, particularly in aseptic manufacturing, the proper management of consumables such as wipes, mops, and garments is critical for maintaining sterility assurance and compliance with Annex 1 requirements. This step-by-step…

Read More “Managing Consumables (Wipes, Mops, Garments) in CCS and EM Programs” »

Long-Term Trending of CCS Effectiveness: What to Track and How Often Long-Term Trending of Contamination Control Strategy Effectiveness in Aseptic Manufacturing The pharmaceutical industry’s commitment to sterility assurance and contamination control is exemplified by stringent regulatory frameworks such as Annex 1 of the EU GMP guidelines. A critical component advancing manufacturing quality is the long-term…

Read More “Long-Term Trending of CCS Effectiveness: What to Track and How Often” »